| Page 826 | Kisaco Research
 

Katherine Delikoura

Managing Director, Chief Compliance Officer
Council Europe Development Bank

Katherine Delikoura

Managing Director, Chief Compliance Officer
Council Europe Development Bank

Katherine Delikoura

Managing Director, Chief Compliance Officer
Council Europe Development Bank
 

Janos Kühn

Global Head of Customer & Third Party Compliance
Ericsson

Janos Kühn

Global Head of Customer & Third Party Compliance
Ericsson

Janos Kühn

Global Head of Customer & Third Party Compliance
Ericsson
 

Ola Tørudbakken,

Director AI Systems
Meta

Ola has 30 years of experience building distributed systems and high-performance networking across AI, HPC, Enterprise and Telco. 

Ola Tørudbakken,

Director AI Systems
Meta

Ola Tørudbakken,

Director AI Systems
Meta

Ola has 30 years of experience building distributed systems and high-performance networking across AI, HPC, Enterprise and Telco. 

Ola currently serves as Director of AI Systems at Meta. Previously Ola was SVP Systems at Graphcore, driving their 2nd generation AI systems. Ola came to Graphcore through the acquisition of Skala Technologies, an AI startup he co-founded. Prior to Skala, Ola worked as Chief Architect of Networking and Netra Servers at Oracle. Ola joined Oracle through the acquisition of Sun Microsystems. At Sun, Ola served as Distinguished Engineer, amongst many things responsible for the famous 3456-port Magnum Infiniband Switch now on display in the Computer Museum, Silicon Valley. Prior to Sun Ola was at Dolphin ICS, acquired by Sun Microsystems in 2000. Ola started his career as a research scientist at SINTEF, a Norwegian industrial research organization.

Ola is a recognized industry expert in distributed systems, holds over 48 patents, has published several papers in leading publications, and participated in numerous standardization bodies. Ola holds an MSc degree in Computer Science from University of Oslo in 1994

PDA Webinar Case Study
 
The Pharma & Biotech Patent Litigation Summit, North America
15-16 Sep 2026
The Royal Sonesta I Boston
The definitive forum for industry leaders shaping the future of life sciences patent litigation. From Hatch-Waxman and BPCIA disputes to skinny labels and ANDA strategies, this event equips you with practical takeaways to stay ahead of evolving patent trends and recent rulings. Covering PTAB strategy, venue selection, and early-stage decision-making, our agenda focuses on how recent decisions and procedural shifts are influencing real-world outcomes in high-stakes pharma and biotech disputes for innovators, generics, biosimilars, and biotechs alike.